Recent Developments in New Sales Channels Fuel CBDL's 18-Month Sales Projections; Company's CBD VaultTM Products' Projected 2025 Sales Revenues to Reach $1.8 Million

SCOTTSDALE, AZ, July 23, 2024 (Newswire.com) - CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, today announced increasing its revenue projection for 2025 to $1.8 million on the strength of its recently launched CBD Vault^TM brand sales. The forecast increase is based both on anticipated organic growth and expected revenue contribution from recently added sales channel partners, as well as rapidly developing opportunities to establish operating partnerships on a more national scale.

"We are extremely pleased with the reception of our CBD Vault^TM brand in the way that it has gained us traction towards establishing greater visibility in the highly competitive CBD products market," said Lisa Nelson, CEO of CBDL. "We are committed to leveraging this greater visibility into ever-stronger sales channel partners that, in turn, will drive us to our future sales objectives."

About The CBD Vault Inc. and CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at www.thecbdvault.com

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: [email protected]

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences Inc.

Source: CBD Life Sciences, Inc.